Lineage Cell Therapeutics Inc LCTX
$1.10 $0.03 (2.65%) 1D
Last Updated: Aug 07, 12:00 AM·XASE
Pricing for US stocks is delayed by 24 hours
LCTX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Lineage Cell Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Lineage Cell Therapeutics Inc. Stock Analysis LCTX
United States Health Care Small Cap Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company is headquartered in Carlsbad, California and currently employs 72 full-time employees. The firm programs are based on a cell-based technology platform, AlloSCOPE, which develops formulation, manufacturing, and delivery capabilities, and serves as the source of its pluripotent cell-based product candidates. Its pipeline includes OpRegen, an allogeneic retinal pigment epithelial (RPE) cell replacement therapy for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (dry-AMD); OPC1, an allogeneic oligodendrocyte progenitor cell therapy for the treatment of spinal cord injuries (SCI); ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant therapy for the treatment of auditory neuropathy; ILT1, an allogeneic cell transplant research initiative for the treatment of Type 1 Diabetes (T1D).
Lineage Cell Therapeutics Inc (LCTX) Chart
Financial Metrics & Statements of Lineage Cell Therapeutics Inc (LCTX)
FAQ's for Lineage Cell Therapeutics Inc (LCTX)
- As of August 2026, Lineage Cell Therapeutics Inc LCTX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lineage Cell Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lineage Cell Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lineage Cell Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lineage Cell Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lineage Cell Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lineage Cell Therapeutics Inc (LCTX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
